Physician profile
Julia Miladore
NPI 1386910263
$4,617.09
in general payments reported to CMS, 2019-2025
19 companies · $591 in 2025
The $591 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $449 · 2021: $556 · 2022: $528 · 2023: $626 · 2024: $625 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,842.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,043.83 | 2021-2024 | Gore Viabahn Endoprosthesis With Heparin, Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cook Medical LLC | $881.03 | 2019-2024 | Zenith |
| Medtronic, INC. | $753.29 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System, In.Pact Admiral |
| Silk Road Medical, INC. | $634.90 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $206.81 | 2021-2022 | |
| Stryker Corporation | $191.82 | 2019-2020 | |
| Medtronic Vascular, INC. | $149.54 | 2019 | |
| Smith+Nephew, INC. | $147.75 | 2020-2025 | Renasys Go V2 Home, Pico 7 |
| Penumbra, INC. | $125.00 | 2020 | |
| Endologix LLC | $123.35 | 2019 | |
| Integra Lifesciences Corporation | $67.89 | 2021 | |
| Pfizer INC. | $60.55 | 2020 | |
| Kci USA, INC. | $58.42 | 2021 | |
| Abbott Laboratories | $47.79 | 2025 | Armada, Esprit |
| Organogenesis INC. | $39.59 | 2022-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $29.52 | 2025 | Alif, Hedron, Lateralalif |
| Kerecis Limited | $21.37 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ekos Corporation | $18.01 | 2019 | |
| Abbvie INC. | $16.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Miladore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.